Author

Suzanne Moreland

Observed names: Moreland, S., S Moreland, S. MORELAND, S. Moreland, SUZANNE MORELAND, Suzanne M. Moreland

Institution: Bristol-Myers Squibb (United States)

Observed institutions: Boston University, Boston Medical Center, University of Miami, Princeton University, Graduate Hospital, Bristol-Myers Squibb (United States), University of Pennsylvania

OpenAlex ID: A5110097771

Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents

1991 · Karnail S. Atwal, Brian N. Swanson, et al. · Journal of Medicinal Chemistry · 794

Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agents

1992 · George C. Rovnyak, Karnail S. Atwal, et al. · Journal of Medicinal Chemistry · 452

Dihydropyrimidine calcium channel blockers. II. 3-Substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines

1990 · Karnail S. Atwal, George C. Rovnyak, et al. · Journal of Medicinal Chemistry · 378

Dihydropyrimidine calcium channel blockers: 2-heterosubstituted 4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines

1990 · Karnail S. Atwal, George C. Rovnyak, et al. · Journal of Medicinal Chemistry · 283

Pharmacologic Profile of the Dihydropyrimidine Calcium Channel Blockers SQ 32,547 and SQ 32,946

1995 · Gary J. Grover, Steven Dzwonczyk, et al. · Journal of Cardiovascular Pharmacology · 258

Venous smooth muscle contains vasoconstrictor ETB-like receptors

1992 · Suzanne Moreland, Diane M. McMullen, et al. · Biochemical and Biophysical Research Communications · 253

The Discovery of Sulfonamide Endothelin Antagonists and the Development of the Orally Active ETA Antagonist 5-(Dimethylamino)-N-(3,4-dimethyl-5- isoxazolyl)-1-naphthalenesulfonamide

1994 · Philip D. Stein, John T. Hunt, et al. · Journal of Medicinal Chemistry · 136

Endothelin increases myofilament Ca2+ sensitivity in alpha-toxin-permeabilized rabbit mesenteric artery.

1992 · J Nishimura, S Moreland, et al. · Circulation Research · 90

PDF

Endothelin-1 and angiotensin-II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for common signaling mechanisms

1994 · H Weber, M L Webb, et al. · Molecular Endocrinology · 89

PDF

Synthesis and biological activity of novel calcium channel blockers: 2,5-dihydro-4-methyl-2-phenyl-1,5-benzothiazepine-3-carboxylic acid esters and 2,5-dihydro-4-methyl-2-phenyl-1,5-benzodiazepine-3-carboxylic acid esters

1987 · Karnail S. Atwal, James L. Bergey, et al. · Journal of Medicinal Chemistry · 75

Dihydropyrimidine calcium channel blockers 51: bicyclic dihydropyrimidines as potent mimics of dihydropyridines

1991 · Karnail S. Atwal, Suzanne Moreland · Bioorganic & Medicinal Chemistry Letters · 72

Quinoxaline N-oxide containing potent angiotensin II receptor antagonists: synthesis, biological properties, and structure-activity relationships

1993 · Kyoung Soon Kim, Ligang Qian, et al. · Journal of Medicinal Chemistry · 70

Transient myosin phosphorylation at constant Ca2+ during agonist activation of permeabilized arteries

1992 · S. Moreland, J. Nishimura, et al. · American Journal of Physiology-Cell Physiology · 65

Biphenylsulfonamide Endothelin Receptor Antagonists. 4. Discovery of N-[[2‘-[[(4,5-Dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1‘-biphenyl]- 2-yl]methyl]-N,3,3-trimethylbutanamide (BMS-207940), A Highly Potent and Orally Active ETA Selective Antagonist

2002 · Natesan Murugesan, Zhengxiang Gu, et al. · Journal of Medicinal Chemistry · 64

Evidence for a differential location of vasoconstrictor endothelin receptors in the vasculature

1994 · Suzanne Moreland, Diane McMullen, et al. · British Journal of Pharmacology · 63

The endothelin receptor antagonist, BQ-123, inhibits angiotensin II-induced contractions in rabbit aorta

1992 · Maria L. Webb, Kenneth E.J. Dickinson, et al. · Biochemical and Biophysical Research Communications · 57

Discovery of N-Isoxazolyl Biphenylsulfonamides as Potent Dual Angiotensin II and Endothelin A Receptor Antagonists

2002 · Natesan Murugesan, John E. Tellew, et al. · Journal of Medicinal Chemistry · 55

Effects of thrombin and thrombin receptor activating peptides on rat aortic vascular smooth muscle.

1993 · M J Antonaccio, D Normandin, et al. · Journal of Pharmacology and Experimental Therapeutics · 55

Molecular characterization of angiotensin II type II receptors in rat pheochromocytoma cells

1992 · Maria L. Webb, Eddie C.-K. Liu, et al. · Peptides · 55

Antihypertensive Effects of a Novel Endothelin-A Receptor Antagonist in Rats

1995 · J. Eileen Bird, Suzanne Moreland, et al. · Hypertension · 54

Studies directed toward ascertaining the active conformation of 1,4-dihydropyridine calcium entry blockers

1988 · George Rovnyak, Niels Andersen, et al. · Journal of Medicinal Chemistry · 51

Functional role of endothelin ETA and ETB receptors in venous and arterial smooth muscle

1995 · Nicholas J. Lodge, Rongan Zhang, et al. · European Journal of Pharmacology · 48

Orally Active Endothelin Receptor Antagonist BMS-182874 Suppresses Neointimal Development in Balloon-Injured Rat Carotid Arteries

1995 · Patricia Ferrer, Maria Valentine, et al. · Journal of Cardiovascular Pharmacology · 47

Biphenylsulfonamide Endothelin Antagonists: Structure−Activity Relationships of a Series of Mono- and Disubstituted Analogues and Pharmacology of the Orally Active Endothelin Antagonist 2‘-Amino- N - (3,4-dimethyl-5-isoxazolyl)-4‘-(2-methylpropyl)[1,1‘-biphenyl]-2-sulfonamide (BMS-187308)

1998 · Natesan Murugesan, Zhengxiang Gu, et al. · Journal of Medicinal Chemistry · 42

BMS-182874 is a selective, nonpeptide endothelin ETA receptor antagonist.

1995 · M L Webb, J E Bird, et al. · Journal of Pharmacology and Experimental Therapeutics · 42

Works count: 94

Citation count: 4,539

H-index: 33

I10-index: 60